Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MAEVA Group is a private U.S. financial-services and advisory firm focused on corporate restructuring, renewal, and special situations investing. The firm is described as a turnaround merchant bank that advises businesses undergoing major transitions and also pursues acquisitions or investments in challenged companies. It is associated with founder and chairman Harry J. Wilson and has been referenced in connection with restructuring work at Genesis HealthCare, but MAEVA itself is not a drug developer, biotech company, or healthcare operating company. Based on the available evidence, MAEVA Group should be classified as a financial and strategic advisory firm rather than a life sciences or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MAEVA Group.